I A MacFarlane
Overview
Explore the profile of I A MacFarlane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
1197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steele C, Powell J, Kemp G, Halford J, Wilding J, Harrold J, et al.
Int J Obes (Lond)
. 2015 May;
39(9):1376-82.
PMID: 25971928
Background/objectives: Obesity is common following hypothalamic damage due to tumours. Homeostatic and non-homeostatic brain centres control appetite and energy balance but their interaction in the presence of hypothalamic damage remains...
2.
Bujawansa S, Thondam S, Steele C, Cuthbertson D, Gilkes C, Noonan C, et al.
Clin Endocrinol (Oxf)
. 2013 Aug;
80(3):419-24.
PMID: 23909507
Objective: To study the presentation, management and outcomes and to apply retrospectively the Pituitary Apoplexy Score (PAS) (United Kingdom (UK) guidelines for management of apoplexy) to a large, single-centre series...
3.
Thondam S, Cuthbertson D, Aditya B, MacFarlane I, Wilding J, Daousi C
Clin Endocrinol (Oxf)
. 2012 Feb;
77(4):635-7.
PMID: 22356092
No abstract available.
4.
Gardner C, Javadpour M, Morgan C, Daousi C, MacFarlane I, Cuthbertson D
Br J Neurosurg
. 2011 Mar;
25(3):337-8.
PMID: 21355768
Over the last decade subarachnoid haemorrhage (SAH) has increasingly been recognised as a cause of hypopituitarism. We report on the case of a patient with evidence of growth hormone deficiency...
5.
Cartwright A, Wallymahmed M, MacFarlane I, Wallymahmed A, Williams G, Gill G
QJM
. 2011 Feb;
104(7):575-9.
PMID: 21285231
Aims: To determine the long-term (20 years from presentation) outcome of brittle type 1 diabetes characterized by recurrent episodes of ketoacidosis (DKA). Methods: The cohort studied was a group of...
6.
Wallymahmed M, Morgan C, Gill G, MacFarlane I
Diabet Med
. 2011 Jan;
28(3):373-9.
PMID: 21204963
Aim: To compare the effects of a dedicated cardiovascular risk factor clinic run by a nurse consultant with routine diabetes clinic attendance in achieving glycaemic and cardiovascular risk targets in...
7.
Gardner C, Wieshmann H, Gosney J, Carr H, MacFarlane I, Cuthbertson D
J Clin Endocrinol Metab
. 2010 Nov;
95(11):4844-5.
PMID: 21051579
No abstract available.
8.
White H, Blair J, Pinkney J, Cuthbertson D, Day R, Weber A, et al.
QJM
. 2010 Mar;
103(5):337-45.
PMID: 20231234
Background: Multiple endocrine neoplasia type 1 (MEN1) is associated with significant morbidity and mortality. Timely detection of MEN1 kindred, together with treatment of associated tumours, results in an improved outcome....
9.
Deepak D, Daousi C, Javadpour M, Clark D, Perry Y, Pinkney J, et al.
Growth Horm IGF Res
. 2010 Feb;
20(3):220-5.
PMID: 20185347
Background: Adult GHD syndrome is associated with clustering of adverse cardiovascular (CV) risk factors such as abnormal body composition, dyslipidemia, insulin resistance and abnormal haemostatic factors. There is a wealth...
10.
Adetunji O, MacFarlane I, Javadpour M, Alfirevic A, Pirmohamed M, Blair J
Eur J Endocrinol
. 2009 Jul;
161(4):541-6.
PMID: 19605543
Context: The growth response to recombinant human growth hormone (rhGH) in GH deficient (GHD) patients may be influenced by polymorphisms in the growth hormone receptor (GHR) gene. Objectives: To investigate...